[Receptor tyrosine kinases. A target for new cancer treatments].
Medinger
Michael
M
Klinik für Internistische Onkologie, Freiburg, Germany. medinger@tumorbio.uni-freiburg.de
Soltau
Jens
J
Unger
Clemens
C
Drevs
Joachim
J
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004815:Epidermal Growth Factor / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000235:genetics; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology
D000970:Antineoplastic Agents; D042461:Vascular Endothelial Growth Factor A; D004815:Epidermal Growth Factor; D020794:Receptor Protein-Tyrosine Kinases